L. González Puig
YOU?
Author Swipe
View article: P149 Clinical worsening in non-adherent belimumab treatment in SLE
P149 Clinical worsening in non-adherent belimumab treatment in SLE Open
Objective The objective is to analyze the association between therapeutic adherence and disease activity in SLE patients. Methods An observational, prospective study in SLE patients (SLICC/ACR criteria), treated whit subcutaneous Belimumab…
View article: P9 Increase of IL10 and INFA2 are associated to clinical activity in systemic lupus erythematous patients
P9 Increase of IL10 and INFA2 are associated to clinical activity in systemic lupus erythematous patients Open
Objective We aimed to analyze the association between inflammatory cytokine levels (IFN-a2, IFN-b, IFN-g, IL10 and BLyS) and disease activity for a 12 months of follow-up in SLE patients. Methods A longitudinal, observational prospective s…
View article: P28 Drug-induced lupus: clinical and serological features in a tertiary hospital
P28 Drug-induced lupus: clinical and serological features in a tertiary hospital Open
Objective Several drugs have been implicated in the development of de novo systemic lupus erythematosus (SLE), unmasking of quiescent SLE or causing an exacerbation of previously diagnosed SLE. Our aim is to describe the causative d…
View article: POS0645 REAL LIFE SAFETY AND SURVIVAL OF TARGETED THERAPIES IN ARTHRITIS PATIENTS OVER AGE OF 65
POS0645 REAL LIFE SAFETY AND SURVIVAL OF TARGETED THERAPIES IN ARTHRITIS PATIENTS OVER AGE OF 65 Open
View article: AB0476 AFTER JAK INHIBITOR FAILURE, ‘SWITCHING’ OR ‘CYCLING‘?
AB0476 AFTER JAK INHIBITOR FAILURE, ‘SWITCHING’ OR ‘CYCLING‘? Open
View article: AB1587 EXPERIENCE IN REAL-WORLD CONDITIONS OF THE EFFECTIVENESS OF THE VACCINE AGAINST HERPES ZOSTER
AB1587 EXPERIENCE IN REAL-WORLD CONDITIONS OF THE EFFECTIVENESS OF THE VACCINE AGAINST HERPES ZOSTER Open
View article: AB1236 OSTEOPOROSIS AND FRACTURES IN PATIENTS UNDERGOING CHRONIC CORTICOSTEROID THERAPY
AB1236 OSTEOPOROSIS AND FRACTURES IN PATIENTS UNDERGOING CHRONIC CORTICOSTEROID THERAPY Open
View article: AB0426 PROFILE OF REFRACTORY RA PATIENTS FOR TARGETED THERAPIES IN REAL LIFE
AB0426 PROFILE OF REFRACTORY RA PATIENTS FOR TARGETED THERAPIES IN REAL LIFE Open
View article: AB0928 USE OF RITUXIMAB IN SYSTEMIC SCLEROSIS PATIENTS WITH PULMONARY AND DIFFUSE CUTANEOUS INVOLVEMENT. A SERIES OF 15 CASES
AB0928 USE OF RITUXIMAB IN SYSTEMIC SCLEROSIS PATIENTS WITH PULMONARY AND DIFFUSE CUTANEOUS INVOLVEMENT. A SERIES OF 15 CASES Open
View article: AB1337 COVID-19 AND JAKI: ANALYSIS AFTER THREE-YEAR PANDEMIC AT A SPANISH TERTIARY CARE HOSPITAL
AB1337 COVID-19 AND JAKI: ANALYSIS AFTER THREE-YEAR PANDEMIC AT A SPANISH TERTIARY CARE HOSPITAL Open
Background The Coronavirus disease (COVID-19) is caused by the SARS-CoV-2 virus, which has led to a world revolution in many spheres, especially in the field of health, for more than three years. It is important to take into account that p…
View article: AB1424 CLINICAL VARIABILITY IN PATIENTS DIAGNOSED OF JUVENILE IDIOPATHIC ARTHRITIS WITH POSITIVE AND NEGATIVE ANTINUCLEAR ANTIBODIES (ANA)
AB1424 CLINICAL VARIABILITY IN PATIENTS DIAGNOSED OF JUVENILE IDIOPATHIC ARTHRITIS WITH POSITIVE AND NEGATIVE ANTINUCLEAR ANTIBODIES (ANA) Open
Background Juvenile Idiopathic Arthritis (JIA) involves a set of chronic arthritis of onset in childhood. JIA can be splitted into 7 categories based on the classification of the International League of Associations for Rheumatology (ILAR)…
View article: PO.3.61 Renal involvement and cardiovascular risk in systemic lupus erythematosus patients
PO.3.61 Renal involvement and cardiovascular risk in systemic lupus erythematosus patients Open
Background Systemic lupus erythematosus (SLE) is an autoimmune disease which generally affects young woman. Kidney affection appears in around 40% of patients and eventually condition the prognosis. Mortality is bimodal: initially is secon…
View article: PO.3.66 TLR9 protein level is associated to proinflammatory cytokine level of IL10 and inf1a in SLE patients
PO.3.66 TLR9 protein level is associated to proinflammatory cytokine level of IL10 and inf1a in SLE patients Open
Purpose The aim is to investigate the association among TLR7 and TLR9 serum levels with previous viral infections, disease activity and proinflammatory cytokine levels in SLE patients. Methods Cross-sectional observational study in SLE pat…
View article: PO.5.116 Lupus nephritis response in terms of kidney function, urine sediment and serological activity after belimumab treatment
PO.5.116 Lupus nephritis response in terms of kidney function, urine sediment and serological activity after belimumab treatment Open
Background Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease characterized by an immune dysregulation and autoantibodies production. Kidney affection appears in around 40% of patients and eventually condition the pro…
View article: PO.8.175 Antimalarial drugs and electrocardiographic alterations in patients with systemic lupus erythematosus
PO.8.175 Antimalarial drugs and electrocardiographic alterations in patients with systemic lupus erythematosus Open
.Background During the first months of the Sars-CoV-2 pandemic, antimalarial drugs were the central axis of the treatment of patients with acute respiratory infection. After that, several studies reported a risk of prolongation of c…
View article: AB1168 CLINICAL AND SEROLOGICAL EVOLUTION OF RHEUMATIC PATIENTS INFECTED BY SARS-COV-2
AB1168 CLINICAL AND SEROLOGICAL EVOLUTION OF RHEUMATIC PATIENTS INFECTED BY SARS-COV-2 Open
View article: POS0067 PULMONARY FUNCTION IN PATIENTS DIAGNOSED OF EARLY SYSTEMIC SCLEROSIS: 10 YEARS EXPERIENCE.
POS0067 PULMONARY FUNCTION IN PATIENTS DIAGNOSED OF EARLY SYSTEMIC SCLEROSIS: 10 YEARS EXPERIENCE. Open
View article: AB1024 SECONDARY PREVENTION OF VERTEBRAL FRACTURES SUSTAINED EFFICACY OVER TIME
AB1024 SECONDARY PREVENTION OF VERTEBRAL FRACTURES SUSTAINED EFFICACY OVER TIME Open
View article: AB0327 CARDIOVASCULAR RISK ASSESSMENT IN RHEUMATOID ARTHRITIS WITH CAROTID ULTRASONOGRAPHY AND CARDIOVASCULAR RISK SCORES: A CASE CONTROL STUDY
AB0327 CARDIOVASCULAR RISK ASSESSMENT IN RHEUMATOID ARTHRITIS WITH CAROTID ULTRASONOGRAPHY AND CARDIOVASCULAR RISK SCORES: A CASE CONTROL STUDY Open
View article: AB0411 IMPACT OF GENDER IN JAK INHIBITORS PRESCRIPTION: ANALYSIS FROM A SINGLE CENTER COHORT
AB0411 IMPACT OF GENDER IN JAK INHIBITORS PRESCRIPTION: ANALYSIS FROM A SINGLE CENTER COHORT Open
View article: AB0435 LUPUS NEPHRITIS RESPONSE IN TERMS OF KIDNEY FUNCTION, URINE SEDIMENT AND SEROLOGICAL ACTIVITY AFTER SUBCUTANEOUS BELIMUMAB TREATMENT
AB0435 LUPUS NEPHRITIS RESPONSE IN TERMS OF KIDNEY FUNCTION, URINE SEDIMENT AND SEROLOGICAL ACTIVITY AFTER SUBCUTANEOUS BELIMUMAB TREATMENT Open
View article: AB0324 SAFETY PROFILE OF JAK INHIBITORS IN REAL WORLD FROM A SINGLE CENTER COHORT
AB0324 SAFETY PROFILE OF JAK INHIBITORS IN REAL WORLD FROM A SINGLE CENTER COHORT Open
View article: AB1256 TRANSITIONAL CARE IN JUVENILE IDIOPATHIC ARTHRITIS: TIMING, PREVALENCE OF SUBTYPES AND TREATMENT PROFILE IN A SPANISH TERTIARY HOSPITAL.
AB1256 TRANSITIONAL CARE IN JUVENILE IDIOPATHIC ARTHRITIS: TIMING, PREVALENCE OF SUBTYPES AND TREATMENT PROFILE IN A SPANISH TERTIARY HOSPITAL. Open
View article: AB1316 PREVALENCE, DIAGNOSTIC DELAY AND TREATMENT PROFILE OF PATIENTS WITH MONOGENIC AUTOINFLAMMATORY DISEASES IN AN ADULT RHEUMATOLOGY SERVICE OF A TERTIARY HOSPITAL.
AB1316 PREVALENCE, DIAGNOSTIC DELAY AND TREATMENT PROFILE OF PATIENTS WITH MONOGENIC AUTOINFLAMMATORY DISEASES IN AN ADULT RHEUMATOLOGY SERVICE OF A TERTIARY HOSPITAL. Open
View article: POS0544 REMOTE MONITORING TOOLS IN RA PATIENTS: FACIT-FATIGUE AND HAQ
POS0544 REMOTE MONITORING TOOLS IN RA PATIENTS: FACIT-FATIGUE AND HAQ Open
View article: AB0233 CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS: A TWO YEARS OBSERVATIONAL STUDY.
AB0233 CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS: A TWO YEARS OBSERVATIONAL STUDY. Open
View article: POS0191 ANTIMALARIAL DRUGS AND ELECTROCARDIOGRAPHIC ALTERATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.
POS0191 ANTIMALARIAL DRUGS AND ELECTROCARDIOGRAPHIC ALTERATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS. Open
View article: AB0534 PROSPECTIVE STUDY OF 24 MONTHS OF EVOLUTION OF A COHORT OF PATIENTS WITH RHUPUS
AB0534 PROSPECTIVE STUDY OF 24 MONTHS OF EVOLUTION OF A COHORT OF PATIENTS WITH RHUPUS Open
View article: POS1365 ANNALYSIS OF PRO-INFLAMMATORY BIOMARKERS IN A POLYMYALGIA RHEUMATICA COHORT DURING THE ACUTE ONSET OF THE DISEASE
POS1365 ANNALYSIS OF PRO-INFLAMMATORY BIOMARKERS IN A POLYMYALGIA RHEUMATICA COHORT DURING THE ACUTE ONSET OF THE DISEASE Open
View article: AB1066 EFFICACY AND SAFETY OF APREMILAST IN BEHÇET DISEASE PATIENTS
AB1066 EFFICACY AND SAFETY OF APREMILAST IN BEHÇET DISEASE PATIENTS Open